Literature DB >> 23365031

The Oswestry Risk Index: an aid in the treatment of metastatic disease of the spine.

B Balain1, A Jaiswal, J M Trivedi, S M Eisenstein, J H Kuiper, D C Jaffray.   

Abstract

The revised Tokuhashi, Tomita and modified Bauer scores are commonly used to make difficult decisions in the management of patients presenting with spinal metastases. A prospective cohort study of 199 consecutive patients presenting with spinal metastases, treated with either surgery and/or radiotherapy, was used to compare the three systems. Cox regression, Nagelkerke's R(2) and Harrell's concordance were used to compare the systems and find their best predictive items. The three systems were equally good in terms of overall prognostic performance. Their most predictive items were used to develop the Oswestry Spinal Risk Index (OSRI), which has a similar concordance, but a larger coefficient of determination than any of these three scores. A bootstrap procedure was used to internally validate this score and determine its prediction optimism. The OSRI is a simple summation of two elements: primary tumour pathology (PTP) and general condition (GC): OSRI = PTP + (2 - GC). This simple score can predict life expectancy accurately in patients presenting with spinal metastases. It will be helpful in making difficult clinical decisions without the delay of extensive investigations.

Entities:  

Mesh:

Year:  2013        PMID: 23365031     DOI: 10.1302/0301-620X.95B2.29323

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  22 in total

1.  [Surgical treatment of skeletal metastases].

Authors:  T Gösling; M Becker-Schiebe
Journal:  Unfallchirurg       Date:  2015-04       Impact factor: 1.000

Review 2.  [Prognosis scores for spinal metastases].

Authors:  N H von der Höh; J Gulow; S K Tschöke; A Völker; C E Heyde
Journal:  Orthopade       Date:  2013-09       Impact factor: 1.087

3.  A validation of the Oswestry Spinal Risk Index.

Authors:  S Whitehouse; J Stephenson; V Sinclair; J Gregory; A Tambe; R Verma; Irfan Siddique; Mohammad Saeed
Journal:  Eur Spine J       Date:  2014-11-13       Impact factor: 3.134

4.  A revision of the Tokuhashi revised score improves the prognostic ability in patients with metastatic spinal cord compression.

Authors:  Søren Schmidt Morgen; Sidsel Fruergaard; Martin Gehrchen; Sebastian Bjørck; Svend Aage Engelholm; Benny Dahl
Journal:  J Cancer Res Clin Oncol       Date:  2017-10-06       Impact factor: 4.553

5.  A systematic review of prognostic factors predicting survival in patients with spinal bone metastases.

Authors:  L Bollen; W C H Jacobs; Y M Van der Linden; O Van der Hel; W Taal; P D S Dijkstra
Journal:  Eur Spine J       Date:  2017-10-24       Impact factor: 3.134

6.  The Oswestry Spinal Risk Index (OSRI): an external validation study.

Authors:  Christina Fleming; Joseph F Baker; Shane C O'Neill; Fiachra E Rowan; Damien P Byrne; Keith Synnott
Journal:  Eur Spine J       Date:  2014-12-25       Impact factor: 3.134

7.  Outcomes of surgical treatments of spinal metastases: a prospective study.

Authors:  C Bouthors; S Prost; C Court; B Blondel; Y P Charles; S Fuentes; H P Mousselard; C Mazel; C H Flouzat-Lachaniette; P Bonnevialle; F Saihlan
Journal:  Support Care Cancer       Date:  2019-08-09       Impact factor: 3.603

8.  The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models.

Authors:  Maryam Dosani; Scott Tyldesley; Brendan Bakos; Jeremy Hamm; Tim Kong; Sarah Lucas; Jordan Wong; Mitchell Liu; Sarah Hamilton
Journal:  Support Care Cancer       Date:  2018-02-01       Impact factor: 3.603

9.  Development and validation of a prognostic nomogram for the overall survival of patients living with spinal metastases.

Authors:  Xiong-Gang Yang; Jiang-Tao Feng; Feng Wang; Xin He; Hao Zhang; Li Yang; Hao-Ran Zhang; Yong-Cheng Hu
Journal:  J Neurooncol       Date:  2019-09-09       Impact factor: 4.130

Review 10.  [Metastatic breast cancer in the spine : Molecular predictors for choosing adequate treatment strategies].

Authors:  D Adler; M Kriegsmann; P Sinn; A Schneeweiss; H Almansour; B Lehner; M Akbar
Journal:  Orthopade       Date:  2018-07       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.